HighTide Therapeutics Completes Patient Enrolment for Phase II Trial of Metabolic Modulator
HighTide Therapeutics Completes Patient Enrolment for Phase II Trial of Metabolic Modulator
HighTide Therapeutics 完成代謝調節劑 II 期試驗的患者入組
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊